Jinpu Yu
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Immunology top 1%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Immunology 46
- Immune Cell Function and Interaction 25
- Immune cells in cancer 13
- Immunotherapy and Immune Responses 9
- Oncology 43
- Cancer Cells and Metastasis 7
- Cancer Immunotherapy and Biomarkers 7
- Chemokine receptors and signaling 7
- Co-authors
- Xiubao Ren (45 shared papers)Wenwen Yu (23 shared papers)Hui Li (18 shared papers)Feng Wei (24 shared papers)Shui Cao (25 shared papers)Yingnan Ye (23 shared papers)Xishan Hao (19 shared papers)Yan Fang (4 shared papers)
- Journals
- Cancer Biotherapy and Radiopharmaceuticals (7 papers)Oncotarget (6 papers)Cancer Immunology Immunotherapy (5 papers)Cancer Biology and Medicine (5 papers)Frontiers in Immunology (5 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Jinpu Yu
120 papers receiving 4.7k citations
Jinpu Yu's Hit Papers
Peers
Comparison fields: 5 of 119
- Cancer Research 1.3k
- Immunology 1.8k
- Biological Psychiatry 189
- Oncology 1.6k
- Molecular Biology 1.6k
Countries citing papers authored by Jinpu Yu
This map shows the geographic impact of Jinpu Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinpu Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinpu Yu more than expected).
Fields of papers citing papers by Jinpu Yu
This network shows the impact of papers produced by Jinpu Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinpu Yu. The network helps show where Jinpu Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jinpu Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 126 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast Cancer Hit paper breakdown → | 2013 | 523 |
| 2 | 2015 | 226 | |
| 3 | 2014 | 191 | |
| 4 | 2013 | 187 | |
| 5 | 2012 | 155 | |
| 6 | 2013 | 133 | |
| 7 | 2015 | 131 | |
| 8 | 2018 | 131 | |
| 9 | 2020 | 129 | |
| 10 | 2012 | 126 | |
| 11 | 2014 | 126 | |
| 12 | 2017 | 102 | |
| 13 | 2012 | 100 | |
| 14 | 2019 | 100 | |
| 15 | 2009 | 98 | |
| 16 | 2013 | 95 | |
| 17 | 2017 | 86 | |
| 18 | 2012 | 86 | |
| 19 | 2017 | 82 | |
| 20 | 2016 | 78 |
About Jinpu Yu
Jinpu Yu is a scholar working on Immunology, Oncology, Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 126 papers that have together received 4.8k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (25 papers), Immune cells in cancer (13 papers), Immunotherapy and Immune Responses (9 papers), MicroRNA in disease regulation (8 papers), Cancer Cells and Metastasis (7 papers), Cancer-related molecular mechanisms research (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Chemokine receptors and signaling (7 papers). The work is most often cited by research in Cancer Research (1.3k citations), Immunology (1.8k citations), Biological Psychiatry (189 citations), Oncology (1.6k citations) and Molecular Biology (1.6k citations). Jinpu Yu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xiubao Ren, Wenwen Yu, Hui Li, Feng Wei, Shui Cao, Yingnan Ye, Xishan Hao, Yan Fang, Pengpeng Liu and Yue Wang. Their work appears in journals such as Cancer Biotherapy and Radiopharmaceuticals, Oncotarget, Cancer Immunology Immunotherapy, Cancer Biology and Medicine and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.